Skip to content
OVCAR-8-Luc
Tissue
卵巢
Disease
腺癌
Metastatic site
原發性腫瘤部位(卵巢)
Synonyms
OVCAR 8, NIH:OVCAR-8, OVCAR8, Ovcar8, OVCAR.8, OVCA8, OVCAR-8/EGFP_LC3

Documents

OVCAR-8-Luc

Cell line · Product number 305697

OVCAR-8-Luc cells are a bioluminescent derivative of the human ovarian adenocarcinoma cell line OVCAR-8, which was originally established from an adult pa...

US$800.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
  • CoA
1

01General information

Description

OVCAR-8-Luc 細胞是人類卵巢腺癌細胞系 OVCAR-8 的生物發光衍生細胞系,該細胞系最初是從一名晚期成人患者身上建立的。 這些細胞經過基因工程改造,可穩定表達螢火蟲酶(luciferase)——這是一種在底物存在下能催化發光的酶,從而實現對細胞活動的高靈敏度、非侵入性監測。 原始的 OVCAR-8 細胞系具有生長兇猛、基因組不穩定,以及高分化度漿液性卵巢癌的典型特徵,因此成為研究卵巢腫瘤生物學的廣泛應用模型。

透過整合螢光素酶,OVCAR-8-Luc 細胞可應用於縱向體內成像,特別是在異種移植與原位腫瘤模型中,可利用生物發光成像技術,隨時間推移定量追蹤腫瘤負荷與轉移擴散情況。 這些細胞保留了親本細胞系的主要分子和表型特徵,包括與卵巢癌進展相關的通路改變,例如 p53 功能失調和細胞週期控制失調。 因此,OVCAR-8-Luc 細胞非常適合用於評估治療療效、腫瘤生長動力學和轉移行為,以及在臨床前研究中探討腫瘤微環境的相互作用。

Tissue
卵巢
Disease
腺癌
Metastatic site
原發性腫瘤部位(卵巢)
Applications
卵巢癌研究;異種移植/原位模型中的生物發光成像;體內腫瘤負荷追蹤;藥物療效與藥理動力學;PARP 抑制劑及鉑類藥物敏感性研究;腹膜轉移模型建立;卵巢癌免疫療法評估
Synonyms
  • OVCAR 8
  • NIH:OVCAR-8
  • OVCAR8
  • Ovcar8
  • OVCAR.8
  • OVCA8
  • OVCAR-8/EGFP_LC3

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
GMO status
GMO-S1
GMO status details
GMO-S1: This cell line contains a stably integrated firefly luciferase reporter cassette (Luc2, codon-optimized) introduced via replication-incompetent lentiviral transduction. The resulting polyclonal cell population was maintained under puromycin selection (1–5 µg/mL). S1 containment is required. This classification applies only within Germany and may differ elsewhere.
Biosafety level
1

03Characteristics

Morphology
上皮樣
Cell type
上皮細胞

04Identifiers

Citation
OVCAR-8-Luc(Cytion 型號 305697)
NCBI TaxID
9606
Cellosaurus
CVCL_2169

05Expression and susceptibility

Antigen expression
Luc2(螢火蟲,密碼子優化)

06Handling and culture

Culture medium
RPMI 1640,含 2.0 mM 穩定谷氨醯胺,含 2.0 g/L NaHCO₃(Cytion 產品編號 820700a)
Incubation atmosphere

37°C,5% CO₂,加濕環境。

Supplements
在培養基中加入 10% 的胎牛血清(FBS)
Dissociation reagent
Accutase
Seeding density
1–3 × 10⁴ 個細胞/mL
Fluid renewal
每週 2 至 3 次
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Quality control and cryopreservation

Freeze medium
作為冷凍保存培養基,我們使用完全生長培養基加上 10% 的二甲基亞砜(DMSO),以確保解凍後的細胞存活率達到適當水準。
Storage conditions

若需長期保存,請將試管置於溫度約為 −150 至 −196 °C 的氣相液氮中。僅在轉移至液氮之前,可將試管暫時存放於 −80 °C 環境中,作為短期過渡步驟。

Shipping conditions

冷凍保存的細胞系會以乾冰冷藏,並裝於經驗證的隔熱包裝中,包裝內含有足夠的冷媒,以確保在運輸過程中溫度維持在約 −78 °C。收到貨物後,請立即檢查容器,並盡快將試管轉移至適當的儲存場所。

08Donor

Donor age
64年
Ethnicity
高加索人